6-1610680-C-T
Variant summary
Our verdict is Pathogenic. The variant received 11 ACMG points: 11P and 0B. PM1PM2PM5PP2PP3_Strong
The NM_001453.3(FOXC1):c.235C>T(p.Pro79Ser) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P79T) has been classified as Pathogenic.
Frequency
Consequence
NM_001453.3 missense
Scores
Clinical Significance
Conservation
Publications
- anterior segment dysgenesis 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
 - Axenfeld-Rieger syndrome type 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
 - aniridiaInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
 - Axenfeld anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Axenfeld-Rieger syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - isolated aniridiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Peters anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 - Rieger anomalyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
 
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 11 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| FOXC1 | NM_001453.3  | c.235C>T | p.Pro79Ser | missense_variant | Exon 1 of 1 | ENST00000645831.2 | NP_001444.2 | 
Ensembl
Frequencies
GnomAD3 genomes  Cov.: 31 
GnomAD4 exome Cov.: 32 
GnomAD4 genome  Cov.: 31 
ClinVar
Submissions by phenotype
Axenfeld-Rieger syndrome type 3    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Different missense substitutions at this codon (p.Pro79Leu, p.Pro79Thr, and p.Pro79Arg) have been reported in individuals affected with anterior segment dysgenesis and Axenfeld-Rieger syndrome (PMID: 11170889, 16936096), and at least one (p.Pro79Thr) has been determined to be pathogenic (PMID: 14506133, 27124303, 11589884). This suggests that the proline residue is critical for FOXC1 protein function and that other missense substitutions at this position may also be pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with FOXC1-related disease. This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with serine at codon 79 of the FOXC1 protein (p.Pro79Ser). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and serine. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at